A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
Clinical trial NCT04294810 · COMPLETED
Trial details
- NCT number
- NCT04294810
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-04
- Primary completion
- 2025-12-30
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.